Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Razuprotafib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio
    Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio

    05 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/quantum-leap-healthcare-collaborative-discontinues-testing-of-aerpio-pharmaceuticals-razuprotafib-in-i-spy-covid-trial-301241760.html

    PRNEWSWIRE
    05 Mar 2021
    Share Share
    Aerpio Announces Strategic Review after Topline Results from Razuprotafib
    Aerpio Announces Strategic Review after Topline Results from Razuprotafib

    05 Jan 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/01/05/2153803/0/en/Aerpio-Announces-Strategic-Review-after-Topline-Results-from-Razuprotafib-Glaucoma-Phase-2-Trial.html

    GLOBENEWSWIRE
    05 Jan 2021
    Share Share
    Aerpio Announces Statistically Significant Topline Results from Razuprotafib
    Aerpio Announces Statistically Significant Topline Results from Razuprotafib

    11 Dec 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/12/11/2144068/0/en/Aerpio-Announces-Statistically-Significant-Topline-Results-from-Razuprotafib-Glaucoma-Phase-2-Trial.html

    GLOBENEWSWIRE
    11 Dec 2020
    Share Share
    Aerpio Announces a Second Trial with Funding from MTEC to Evaluate Razuprotafib
    Aerpio Announces a Second Trial with Funding from MTEC to Evaluate Razuprotafib

    04 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/04/2072868/0/en/Aerpio-Pharmaceuticals-Inc-Announces-a-Second-Clinical-Trial-with-Funding-from-MTEC-to-Evaluate-Razuprotafib-for-the-Prevention-and-Treatment-of-ARDS-in-Patients-with-Moderate-to-S.html

    GLOBENEWSWIRE
    04 Aug 2020
    Share Share
    Aerpio and Quantum Leap to study razuprotafib for ARDS in Covid-19
    Aerpio and Quantum Leap to study razuprotafib for ARDS in Covid-19

    28 May 2020

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/aerpio-quantum-razuprotafib-ards/

    CLINICALTRIALSARENA
    28 May 2020
    Share Share
    Aerpio Pharmaceuticals and Quantum Leap Healthcare Collaborative Razuprotafib
    Aerpio Pharmaceuticals and Quantum Leap Healthcare Collaborative Razuprotafib

    27 May 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/27/2039771/0/en/Aerpio-Pharmaceuticals-Inc-and-Quantum-Leap-Healthcare-Collaborative-Announce-the-Selection-of-Razuprotafib-for-Evaluation-in-the-I-SPY-COVID-Trial-for-the-Treatment-of-Acute-Respi.html

    GLOBENEWSWIRE
    27 May 2020
    Share Share